Cyclic AMP and butyrate modulate melatonin synthesis in Y79 human retinoblastoma cells (Journal article)

Wiechmann, A. F./ Kyritsis, A. P./ Fletcher, R. T./ Chader, G. J.


Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiechmann, A. F.en
dc.contributor.authorKyritsis, A. P.en
dc.contributor.authorFletcher, R. T.en
dc.contributor.authorChader, G. J.en
dc.date.accessioned2015-11-24T19:25:49Z-
dc.date.available2015-11-24T19:25:49Z-
dc.identifier.issn0022-3042-
dc.identifier.urihttp://olympias.lib.uoi.gr/jspui/handle/123456789/22659-
dc.rightsDefault Licence-
dc.subjectAcetylserotonin O-Methyltransferase/metabolismen
dc.subjectArylamine N-Acetyltransferase/metabolismen
dc.subjectBucladesine/*pharmacologyen
dc.subjectButyrates/*pharmacologyen
dc.subjectButyric Aciden
dc.subjectButyric Acids/*pharmacologyen
dc.subjectEye Neoplasms/*metabolism/pathologyen
dc.subjectHumansen
dc.subjectMelatonin/*biosynthesisen
dc.subjectNeoplasm Proteins/metabolismen
dc.subjectRetinoblastoma/*metabolism/pathologyen
dc.subjectTumor Cells, Cultureden
dc.titleCyclic AMP and butyrate modulate melatonin synthesis in Y79 human retinoblastoma cellsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2162375-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1990-
heal.abstractMelatonin is synthesized by cultured Y79 human retinoblastoma cells and is secreted into the medium. Activity of the two key enzymes involved in the synthesis of melatonin, N-acetyltransferase (NAT) and hydroxyindole-O-methyltransferase (HIOMT), are present in retinoblastoma cells. The activity of these enzymes and the resulting synthesis and release of melatonin are modulated by the addition of a cyclic AMP analogue and butyrate to the culture medium. Melatonin levels increase dramatically over control levels after the addition of dibutyryl cyclic AMP (dbcAMP), whereas melatonin levels decrease after butyrate treatment. HIOMT activity is inhibited by both dbcAMP and butyrate, and NAT activity is stimulated by both of these differentiating agents, suggesting that the rise in melatonin levels in response to dbcAMP is the result of increased activity of NAT, whereas the decline in melatonin levels in response to butyrate may be due to a drop in HIOMT activity. Melatonin synthesis is dose- and time-dependent, and the effect of dbcAMP is readily reversible, whereas the effect of butyrate does not appear to be reversible. These effects probably reflect basic differences in the regulatory mechanisms of the inducing agents.en
heal.journalNameJ Neurochemen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.



 Please use this identifier to cite or link to this item:
http://olympias.lib.uoi.gr/jspui/handle/123456789/22659
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.